Table 2. Joinpoint analysis for ASIR, ASMR and ASR of DALY rate of colorectal cancer by sex in China and the U.S. between 1990 and 2019.
Measure | Location | Sex | Trend 1 | Trend 2 | Trend 3 | Trend 4 | Trend 5 | Trend 6 | 1990−2019 AAPC (95% CI) |
|||||||||||
Years | APC | Years | APC | Years | APC | Years | APC | Years | APC | Years | APC | |||||||||
ASIR, age-standardized incidence rate; ASMR, age-standardized mortality rate; DALY, disability-adjusted life-year; ASR, age-standardized rate; APC, annual percentage change; AAPC, average annual percentage change; 95% CI, 95% confidence interval; NA, not applicable; *, significantly different from zero, P<0.05. | ||||||||||||||||||||
ASIR | China | Both | 1990−1996 | 0.79* | 1996−2000 | 3.55* | 2000−2004 | 7.53* | 2004−2011 | 4.18* | 2011−2016 | 0.30 | 2016−2019 | 3.69* | 3.11* (2.89, 3.33) | |||||
Female | 1990−1996 | 0.40* | 1996−2000 | 2.45* | 2000−2004 | 5.37* | 2004−2010 | 3.21* | 2010−2016 | −0.12 | 2016−2019 | 3.65* | 2.16* (1.94, 2.38) | |||||||
Male | 1990−1996 | 1.08* | 1996−2000 | 4.46* | 2000−2004 | 8.80* | 2004−2011 | 5.08* | 2011−2016 | 0.88* | 2016−2019 | 3.45* | 3.75* (3.48, 4.03) | |||||||
the U.S. | Both | 1990−1994 | 1.06* | 1994−2002 | −0.38* | 2002−2006 | −2.85* | 2006−2019 | −0.24* | NA | NA | NA | NA | −0.47* (−0.71, −0.22) | ||||||
Female | 1990−1994 | 0.94* | 1994−2002 | −0.15 | 2002−2006 | −2.75* | 2006−2019 | −0.42* | NA | NA | NA | NA | −0.49* (−0.71, −0.27) | |||||||
Male | 1990−1994 | 1.08* | 1994−2002 | −0.74* | 2002−2006 | −2.88* | 2006−2015 | −0.38* | 2015−2019 | 0.65 | NA | NA | −0.48* (−0.76, −0.21) | |||||||
ASMR | China | Both | 1990−1996 | −0.11 | 1996−1999 | 1.36 | 1999−2004 | 4.41* | 2004−2011 | 1.13* | 2011−2016 | −1.37* | NA | NA | 1.05* (0.83, 1.27) | |||||
Female | 1990−1998 | −0.51* | 1998−2004 | 2.55* | 2004−2011 | −0.01* | 2011−2015 | −2.51* | 2015−2019 | 0.97* | NA | NA | 0.16* (0.03, 0.29) | |||||||
Male | 1990−1995 | 0.02 | 1995−1999 | 1.93* | 1999−2004 | 5.53* | 2004−2011 | 2.10* | 2011−2017 | −0.59* | 2017−2019 | 1.84 | 1.71* (1.45, 1.98) | |||||||
the U.S. | Both | 1990−2002 | −1.04* | 2002−2006 | −2.80* | 2006−2014 | −1.08* | 2014−2019 | 0.35 | NA | NA | NA | NA | −1.06* (−1.23, −0.89) | ||||||
Female | 1990−2001 | −0.89* | 2001−2007 | −2.24* | 2007−2013 | −1.23* | 2013−2019 | −0.17 | NA | NA | NA | NA | −1.09* (−1.24, −0.94) | |||||||
Male | 1990−1995 | −0.73* | 1995−1998 | −2.09* | 1998−2002 | −1.05* | 2002−2006 | −3.06* | 2006−2014 | −1.09* | 2014−2019 | 0.65* | −1.10* (−1.33, −0.87) | |||||||
ASR of DALY |
China | Both | 1990−1996 | −0.48* | 1996−1999 | 1.14 | 1999−2004 | 4.31* | 2004−2011 | 0.94* | 2011−2016 | −1.32* | 2016−2019 | 1.56* | 0.91* (0.72, 1.09) | |||||
Female | 1990−1997 | −0.71* | 1997−2001 | 1.07* | 2001−2004 | 2.04* | 2004−2011 | −0.39* | 2011−2015 | −2.40* | 2015−2019 | 0.92* | −0.12 (−0.27, 0.03) | |||||||
Male | 1990−1996 | −0.25 | 1996−1999 | 1.93* | 1999−2004 | 5.99* | 2004−2011 | 1.83* | 2011−2016 | −0.84* | 2016−2019 | 1.41* | 1.60* (1.36, 1.84) | |||||||
the U.S. | Both | 1990−1995 | −0.60* | 1995−1998 | −1.85* | 1998−2001 | −0.30 | 2001−2006 | −2.33* | 2006−2013 | −0.85* | 2013−2019 | 0.24 | −0.88* (-1.13, −0.64) | ||||||
Female | 1990−2002 | −0.95* | 2002−2006 | −2.35* | 2006−2012 | −1.17* | 2012−2019 | −0.03 | NA | NA | NA | NA | −0.97* (−1.13, −0.81) | |||||||
Male | 1990−1995 | −0.52* | 1995−1998 | −2.18* | 1998−2002 | −0.84* | 2002−2006 | −2.71* | 2006−2014 | −0.65* | 2014−2019 | 0.53* | −0.90* (−1.14, −0.66) |